Ciprofloxacin (Cipro) incorporation into Li-fluorhectorite (LiFh) clay and its temperaturecontrolled release. with potential pharmaceutical and biomedical applications.
nm (from XRD) 1.7 nm (from XRD)
Cipro release from a colloidal suspension of LiFh-Cipro 
LiFh clay
LiFh-Cipro composite *Graphical Abstract
Introduction
Temperature-controlled drug release is desirable in many scenarios: for example, when the local body temperature varies during different stages of a disease, or in response to external stimuli. To date, just a few materials able to release an active principle as a function of temperature have been investigated. In recent years, hydrogel-based composites have been created to release proteins [1, 2] , as well as microscale polymers able to release small molecules and nanoparticles within a certain temperature range [3] .
In the last years, different porous materials have been used as drug hosts [4, 5] . Among clay minerals, montmorillonite is the most commonly used for drug delivery applications [6, 7] , although kaolin and laponite have been also investigated [8] . Most of them have been typically used as hosts for pH-controlled release.
Synthetic hectorites show a number of advantages as drug hosts, like controllable pore size distribution, purity and composition, which result in higher reproducibility. In addition, these materials have been shown to be non-toxic for trans-dermal application and oral administration [5, 9] . Their swelling transition [10] , on the other hand, suggests their potential as hosts of large molecules of pharmaceutical interest and their temperature controlled release. However, few reports about the use of fluorohectorite, a commercially available synthetic smectite, as a drug hosting material, can be found in the literature [5, 6, 11] . From the structural point of view, in their dry form, the layers assemble to form stack-of-card like particles. Figure 1a shows the atomic structure of lithium fluorohectorite (LiFh) clay. The stacks are held together by van der Waals forces, and by electrostatic forces in the case of clays with negative layer charges. In the interlayer space of these clays there are positive counter-ions, leading to an attractive interaction similar to a salt bridge [12, 13] , and they can also take up water between lamellae [14, 15] . In order to take advantage of the temperature-dependent swelling property of these materials, we attempted to incorporate drugs with molecular dimensions of the order of the interlayer space reached when the clay is thermally activated, and different structural features. In the present work, we have successfully incorporated the antibiotic ciprofloxacin (a broadspectrum antibacterial agent for oral administration used to treat various bacterial infections) into a Li-fluorohectorite (LiFh). Figure 1b illustrates the Cipro molecular structure. X ray diffraction (XRD) data suggests a true intercalation of the drug molecules between the clay layers. In addition, thermogravimetric analysis was performed as a complementary method, and the obtained results confirm the observation from the scattering data. We have also investigated the release of the drug molecules from the colloidal clay suspension, which shows a temperaturecontrolled release of the drug. The release profiles meet the pharmaceutical standards for these kinds of systems. We will call the obtained composites Temperature Controlled Release Systems (TCRS).
Material and methods

Sample preparation and characterization
Sample preparation
The chemical composition of fluorohectorite synthetic 2:1 smectite clay is M x (Mg 6-x Li x )F 4 Si 8 O 20 , where M denotes the exchangeable cations. These clay particles are polydisperse with lateral dimensions of the order of μm and they possess a net negative surface charge (x e − per unit cell), which is balanced by counter ions localized between clay lamellar sheets. Ideally x = 1.2 [16] .
We purchased Li-fluorohectorite (LiFh) from Corning Inc., New York, which we characterized by X-ray diffraction (XRD) and Atomic Absorption Spectrometry (AAS) using the procedures described in the next section. From those studies we conclude that the purchased Two different modified forms, Na-fluorohectorite (Na-Fh) and Cu-fluorohectorite (Cu-Fh)
were prepared according to the ionic exchange procedure described in [17] . Ciprofloxacin hydrochloride, acetaminophen and ibuprofen ⎯pharmaceutical-grade according to Pharmacopoeia [18] ⎯ were the model drugs studied; and they were used as received from the Cuban pharmaceutical industry.
For the interactions, 50 ml of drug solutions at 3 mg/ml (pH near 4.5) were put in contact with 0.5 g of each clay, resulting in a colloidal suspension. The experiments were carried out at room temperature and at 65°C ± 5°C during 4 h and 24 h, in order to study the influence of temperature and time on the amount of drug captured by the clays. All these studies took place under agitation with a magnetic stirrer. By the end of the interactions, the pH of the Cipro-clay suspensions was around 8. In the case of drug adsorption in the suspensions, the drugs concentrations before and after the contact with the clays were analyzed and quantified by ultraviolet spectroscopy (UV), according to standard procedures [18] (the drug-clay suspensions were centrifuged, and the drug contents in the supernatant was determined by UV relative to calibration curves for the pure drug solutions). The UV spectra were collected by means of a Rayleígh UV-2601 spectrophotometer in the wavelength interval 200-400 nm (including the adsorption maxima at 276, 245 and 273 nm for the ciprofloxacin, acetaminophen and ibuprofen, respectively). Each composite LiFh-Cipro, NaFh-Cipro and CuFh-Cipro was prepared in several batches, in order to check repeatability. As demonstrated below, the UV studies show that, among the drugs investigated, only Cipro is significantly captured by the clay, so further characterization was performed only on Cipro-clay composites.
Characterization
Each Cipro-clay suspension was centrifuged, and the resulting supernatant fluid was analyzed by means of atomic absorption spectroscopy to determine the ionic contents. A PYE UNICAM SP9 atomic absorption spectrophotometer was employed.
The X-ray diffraction (XRD), for the different clays before and after the drug sorption, were conducted at a Philips Xpert diffractometer, using Cu Kα radiation (λ = 1.54 Å). The 2θ range was from 2 to 40°. wavenumber interval 400-4000 cm -1 , was used. The samples were prepared using the KBr pressed-disk technique, with 0.8% inclusion of the material to be analyzed.
Drug release
The studies of Cipro release from the composites were carried out for LiFh clay. Colloidal suspensions were obtained by putting in contact approximately 30 mg of the powdered composite (equivalent to 8.3 mg of ciprofloxacin determined by UV as described before) with 50 ml of synthetic gastric juice without pepsine at 37 ± 1°C ─according to the method reported in the Pharmacopoeia for this kind of systems [18] , and 100 rpm stirring. Release studies under identical conditions but at 65 ± 5°C were also carried out in order to evaluate the temperature dependence of the Cipro release from clay. For both temperatures, aliquots of the solutions were collected at scheduled intervals and centrifuged. Each time, the supernatant was removed and replaced with 2 ml of synthetic gastric juice. The drug concentration in the solution as a function of time was measured by UV spectroscopy. The experiments were made in triplicate and the average values are reported.
Results and Discussion
Drug intercalation
The UV measurements demonstrated that, among the three drugs investigated, only Cipro shows a significant affinity with the LiFh clay. No clay─drug interaction could be detected in the case of acetaminophen and ibuprofen under the conditions described above.
When sampled by UV at 4 h and 24 h, the same amount of drug incorporation was measured (277 mg of Cipro per gram of clay; equivalent to 8.3 mg of Cipro per 30 mg of composite).Thus, in the following we use 4 h as the sorption time for our samples.
We also tested Na-Fh and Cu-Fh, and we observed that the former was able to incorporate Cipro, while the latter was not, under the present experimental conditions. But in the present study we will only concentrate on LiFh.
Chemical and physical characterization of samples
For Atomic Absorption Spectrometry (AAS) measurements, 0.1 g of LiFh was digested overnight using HCl, HF and HClO4 in 100 ml of water. After that, the dissolutions were analyzed by mean of standard AAS (PYE UNICAM SP9). The whole process was replicated five times The XRD characterization confirmed the presence of Li 2 O⋅2SiO 2 impurities, and that they were not involved in the Cipro capture, since its main Bragg peaks [19] did not show any shifts in positions after contact with the Cipro solution. Using XRD we studied (001) Bragg scattering from the clay stacks. Figure 2 shows the diffraction patterns for LiFh and LiFh-Cipro composite.
In the case of the native LiFh sample there is one layer of water intercalated in the stacks in ambient conditions (peak marked as (a) in the figure) [20] . The LiFh-Cipro samples under study were prepared as described above (4h interaction and pH near 8). The XRD pattern for LiFhCipro shows four peaks marked as b-e in the figure. Peak (b) is likely due to clay stacks in the composite that only have two layers of water intercalated [20] . Peak (c) represents clay stacks with Cipro intercalated (Cipro is a much larger molecule than water and produces a much larger d-spacing increase). Peaks (d) and (e) most likely correspond to one and two layers of water intercalated in addition to the Cipro, respectively. A sketch of the atomic structure of LiFh with intercalated Cipro is shown in Figure 3 .
IR transmittance spectra for Cipro, LiFh and the LiFh-Cipro composite are shown in Fig. 4 .
The characteristic O─H and Si─O bands of the LiFh sample are assigned in the spectrum (see The band at 1707 disappears in the composite LiFh-Cipro spectrum. A possible explanation of this is as follow: The natural pH of a pure Cipro solution and the natural pH of the pure clay in aqueous suspension measured by us is about 4.5 and 10, respectively. We also measure the pH of the Cipro-clay suspension to be around 8. This high pH value leads to de-protonation of the carboxylic group, which results in the C=O bond becoming two more or less equivalent C─O bonds. Therefore, the peak corresponding to ─COOH disappears from the LiFh-Cipro spectrum, and is replaced by two peaks at 1581 and 1390 cm -1 , which may be assigned to asymmetric (νasCOO − ) and symmetric (νsCOO − ) stretching vibrations of the ─COO − group, respectively. This is attributed to the existence of the ciprofloxacin in zwitterionic form, where the COO ─ group is deprotonated and the piperazinyl group is protonated [25, 26] . In addition, due to the COOH group deprotonation and loss of the carboxylic acid C=O stretching, a significant decrease in intensity the coupled COOH modes at 1271 cm -1 was also observed. This behaviour has been observed previously in similar systems [23, 27] . ciprofloxacin. This suggests that it is reasonable to assume that an important proportion of the Cipro is captured by the clay in the powder.
To understand the mechanisms involved, six standard models [30] applied to slow release systems were considered to describe the data. Within the error bars, our data can be well fitted by the zero order model [30] . Q t =Q e + k 0 t with Q e = 0 and k 0 = 0,76 and 1,93 for 37 o C and 65 o C,
respectively. This means that, for both temperatures the release follows an anomalous diffusion.
This implies that the composite releases the same amount of drug per unit time, which is an ideal method of drug release for achieving sustained pharmacological action. 
Conclusion
We 
